Life sciences · Journal article
Frontiers in Digital Health · September 30, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background Pulmonary hypertension (PH) is a heterogeneous condition in which hemodynamic subtype directs management and specialist referral. PH can be identified non-invasively at the point of care by a previously developed, regulatory-cleared machine-learned diagnostic (area under the receiver operating characteristic curve 0.95, sensitivity 82%, specificity 92%), but a positive test result raises a second clinical question: which patients have pre-capillary disease and therefore warrant referral to a specialist PH center. A probabilistic post-test phenotyping model was developed to estimate hemodynamic subtype probabilities and support rule-out of pre-capillary PH among test-positive patients. Methods Subjects with right heart catheterization (RHC)-confirmed PH [mean pulmonary artery pressure (mPAP) ≥25 mmHg] enrolled in a prospective multisite trial (NCT04031989) who tested positive on the previously validated point-of-care PH diagnostic formed the analysis cohort ( n = 139). Hemodynamic subtypes were assigned per 2015 European Society of Cardiology/European Respiratory Society (ESC/ERS) criteria. A one-vs.-one (OvO) Gaussian mixture model (GMM) framework, combining unsupervised clustering with post hoc supervised assignment of subtype probabilities was applied to features derived from non-invasive orthogonal voltage gradient and photoplethysmographic signals to generate subject-level subtype probability estimates. Blinded validation in a large dataset has not yet been performed; development results are reported, supported by a small blinded independent dataset. Results At an exemplar post-hoc rule-out threshold of 16% pre-capillary probability, the GMM OvO approach yielded sensitivity 86% (95% CI: 71%–95%), specificity 51% (95% CI: 41%–61%), negative predictive value 88% (95% CI: 73%–96%) at an assumed pre-capillary prevalence of 34%, and a negative likelihood ratio (LR−) of 0.27 (95% CI: 0.07–0.70) on the development cohort. Supportive out-of-sample discrimination was observed in the blinded independent cohort. Conclusions A GMM OvO probabilistic model applied to non-invasive point-of-care signals can generate PH subtype probability estimates and may support rule-out of pre-capillary disease among true-positive patients. The model reuses signals already acquired for PH detection and can therefore be implemented as a software addition to an existing point-of-care workflow. Independent blinded validation is required to comprehensively characterize model performance.